搜尋結果
BioNTech is a fully integrated, global immunotherapy powerhouse. We have been working on automated and digitized processes and build continuously capabilities for specialized manufacturing, either for individualized vaccines or for large-scale products like our COVID-19 vaccine. We are also continuously evaluating ways to democratize the access ...
2021年1月25日 · 顧問專家委員會已向食物及衞生局局長提交建議，認為在現時疫情情況下，認可使用復星醫藥／德國藥廠BioNTech的新冠疫苗作為預防2019冠狀病毒病的效益大於風險。. 食物及衞生局局長經參考顧問專家委員會的意見，並考慮2019冠狀病毒病對公眾健康構成的威脅 ...
Werde Teil unserer Mission, mit neuartigen Immuntherapien und Impfstoffen weltweit die Gesundheit zu verbessern. BioNTech wächst - deshalb können wir vielfältige Einstiegsmöglichkeiten in Forschung, Entwicklung, Operations, Commercial und Enabling Functions anbieten. Finde mehr heraus über unsere Kultur, Benefits, Standorte und finde den richtigen Job für Dich.
2021年10月19日 · Research & Ratings BioNTech SE ADR (BNTX) Per-Share Earnings, Actuals and Estimates Quarterly Annual BNTX will report Q2 earnings on 08/05/2024 Actual Analyst Range Consensus 5.00 2.50 0.00-2.50-5 ...
Here you can find all media data in an overview for download. Videos, photos, press releases or data sheets Learn more about BioNTech! ... BioNTech SE holds all copy and distribution rights to the pictures on this website. Use of images requires indication of the ...
2020年11月13日 · Just two weeks after the genetic sequence of Sars-Cov-2 was made public on January 12, BioNTech began its Covid-19 vaccine programme. It was a small community, and even within the small [mRNA ...
BioNTech SE（德語發音： [ˈbaɪɒnˌtek]；NASDAQ：BNTX）被譯為生物新技術公司或拜恩泰科 [2] [3]，是一家位於德國 美因茨的生物技術公司，主要業務為開發和生產針對特定患者的治療嚴重疾病的有效免疫治療 [1]。它開發基於信使核糖核酸（mRNA）的候選藥物，用作個體化的癌症免疫療法，傳染性疾病的 ...
